Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Herbalife Nutrition Ltd (HLF) Price & Performance

BBVA trades at $28.545, up 0.69% today, with a bullish technical signal from moving averages but overbought RSI readings. The bank reported strong Q2 2026 earnings, beating estimates with an 11.4% net profit rise, and announced a $2.3 billion share buyback. Revenue growth has been steady, reaching $39.42 billion in 2025, with a net income margin of 26.13% and ROE of 18.5%, though valuation ratios like P/E of 12.98 and P/S of 3.27 suggest moderate pricing.

Outlook remains positive with analyst consensus at 53.85% buy ratings, driven by profitability improvements and strategic initiatives. Key risks include regulatory probes in Spain and antitrust investigations, which could impact sentiment. Investors should weigh solid fundamentals against legal uncertainties for balanced exposure.

Herbalife (HLF) trades at $11.695, up 1.52% on the day, with a bearish technical outlook per moving averages. The company reported Q2 2026 net sales of $1.3 billion, a 5.4% year-over-year increase, though EPS of $0.51 missed estimates. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24. Positive news includes being named to TIME's America's Best Companies 2026 list, but a planned CFO transition in December 2026 introduces uncertainty.

The outlook is mixed; strong sales growth and low valuation metrics offer potential upside, but recent earnings misses, a high debt load, and negative shareholder equity pose significant risks. Analyst consensus leans bullish with 53.84% buy ratings, yet the stock faces headwinds from competitive pressures and margin volatility.